363 related articles for article (PubMed ID: 30002349)
1. New Insights in Anti-Angiogenesis in Multiple Myeloma.
Ribatti D; Vacca A
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30002349
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic therapeutic approaches in multiple myeloma.
Ribatti D; Mangialardi G; Vacca A
Curr Cancer Drug Targets; 2012 Sep; 12(7):768-75. PubMed ID: 22780844
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in multiple myeloma.
Vacca A; Ria R; Reale A; Ribatti D
Chem Immunol Allergy; 2014; 99():180-96. PubMed ID: 24217610
[TBL] [Abstract][Full Text] [Related]
4. Role of tumour angiogenesis in haematological malignancies.
Medinger M; Passweg J
Swiss Med Wkly; 2014; 144():w14050. PubMed ID: 25375891
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis.
Ribatti D; Nico B; Vacca A
Int Rev Cell Mol Biol; 2015; 314():259-82. PubMed ID: 25619720
[TBL] [Abstract][Full Text] [Related]
6. Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome.
Mileshkin L; Honemann D; Gambell P; Trivett M; Hayakawa Y; Smyth M; Beshay V; Ritchie D; Simmons P; Milner AD; Zeldis JB; Prince HM
Haematologica; 2007 Aug; 92(8):1075-82. PubMed ID: 17640854
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis in multiple myeloma.
Rajkumar SV; Kyle RA
Semin Oncol; 2001 Dec; 28(6):560-4. PubMed ID: 11740809
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of angiogenesis and matrix metalloproteinase-2 secretion in bone marrow of multiple myeloma patients before and after the treatment.
Bolkun L; Lemancewicz D; Sobolewski K; Mantur M; Semeniuk J; Kulczynska A; Kloczko J; Dzieciol J
Adv Med Sci; 2013; 58(1):118-25. PubMed ID: 23333895
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors and modulators of angiogenesis in multiple myeloma.
Ferrarini M; Ferrero E
Curr Med Chem; 2011; 18(34):5185-95. PubMed ID: 22087819
[TBL] [Abstract][Full Text] [Related]
10. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma.
Ribatti D; Nico B; Vacca A
Oncogene; 2006 Jul; 25(31):4257-66. PubMed ID: 16518413
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow angiogenesis in multiple myeloma.
Vacca A; Ribatti D
Leukemia; 2006 Feb; 20(2):193-9. PubMed ID: 16357836
[TBL] [Abstract][Full Text] [Related]
12. [New observations support the significance of angiogenesis in myeloma].
Lundberg LG; Lerner R; Palmblad J
Lakartidningen; 2001 Nov; 98(45):4985-90. PubMed ID: 11816901
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis in hematologic malignancies and its clinical implications.
Yang R; Han ZC
Int J Hematol; 2002 Apr; 75(3):246-56. PubMed ID: 11999351
[TBL] [Abstract][Full Text] [Related]
14. Recent studies on the thalidomide and its derivatives.
Łączkowski KZ; Baranowska-Łączkowska A
Future Med Chem; 2018 Sep; 10(18):2133-2136. PubMed ID: 30088422
[No Abstract] [Full Text] [Related]
15. [Bone marrow angiogenesis in multiple myeloma: new insights into the pathogenesis, and development of a new therapeutic approach].
Hattori Y; Kakimoto T
Rinsho Ketsueki; 2000 May; 41(5):426-9. PubMed ID: 10879105
[No Abstract] [Full Text] [Related]
16. Macrophages in multiple myeloma.
Ribatti D; Moschetta M; Vacca A
Immunol Lett; 2014 Oct; 161(2):241-4. PubMed ID: 24370642
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow angiogenesis and progression in multiple myeloma: clinical significance and therapeutic approach.
Eleutherakis-Papaiakovou V; Karali M; Kokkonouzis I; Tiliakos I; Dimopoulos MA
Leuk Lymphoma; 2003 Jun; 44(6):937-48. PubMed ID: 12854891
[TBL] [Abstract][Full Text] [Related]
18. Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.
Lamanuzzi A; Saltarella I; Ferrucci A; Ria R; Ruggieri S; Racanelli V; Rao L; Annese T; Nico B; Vacca A; Ribatti D
Oncotarget; 2016 Mar; 7(12):14510-21. PubMed ID: 26919105
[TBL] [Abstract][Full Text] [Related]
19. Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment.
Tian X; Sun M; Wu H; Chen C; Li H; Qiu S; Wang T; Han J; Xiao Q; Chen K
Leuk Res; 2021 Jun; 105():106566. PubMed ID: 33848709
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in multiple myeloma.
Jakob C; Sterz J; Zavrski I; Heider U; Kleeberg L; Fleissner C; Kaiser M; Sezer O
Eur J Cancer; 2006 Jul; 42(11):1581-90. PubMed ID: 16797965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
